Identification of natural ligands of retinoic acid receptor-related orphan receptor α ligand-binding domain expressed in Sf9 cells - A mass spectrometry approach

Analytical Biochemistry

Volumn 323, Issue 1, 2003, Pages 139-149

  Bitsch, Francis ^a   Aichholz, Reiner ^a   Kallen, Joerg ^a   Geisse, Sabine ^a   Fournier, Brigitte ^a   Schlaeppi, Jean Marc ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cholesterol; Electrospray ionization; Mass spectrometry; Noncovalent complex; Retinoic acid receptor related orphan receptor alpha; ROR

Indexed keywords

CHOLESTEROL; ELECTRODEPOSITION; ELECTROSPRAY IONIZATION; GAS CHROMATOGRAPHY; IONIZATION OF GASES; MASS SPECTROMETRY; SULFUR COMPOUNDS;

CHOLESTEROL SULFATES; ELECTROSPRAY IONIZATION MASS SPECTROMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRIES (GC-MS); LIGAND BINDING DOMAIN; LIGAND EXCHANGES; NATURAL LIGANDS; NON-COVALENT COMPLEXES; RETINOIC ACID RECEPTORS;

LIGANDS;

7 DEHYDROCHOLESTEROL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; CHOLESTEROL SULFATE; GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 PEPTIDE; LIGAND; PEPTIDE DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STOICHIOMETRY;

EID: 0242438098     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2003.08.029     Document Type: Article

References (42)

1. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science. 294:2001;1866-1870.
2. Jetten A.M., Kurebayashi S., Ueda E. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog. Nucleic Acid Res. 69:2001;205-247.
3. Carlberg C., van Huijsduijnen R.H., Staple J.K., DeLamarter J.F., Becker-Andre M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol. 8:1994;757-770.
4. Giguere V., Tini M., Flock G., Ong E., Evans R.M., Otulakowski G. Isoform-specific amino-terminal domains dictate DNA-binding properties of RORα, a novel family of orphan hormone nuclear receptors. Genes Dev. 8:1994;538-553.
5. Vu-Dac N., Gervois P., Grötzinger T., De Vos P., Schoonjans K., Fruchart J.-C., Auwerx J., Mariani J., Tedgui A., Staels B. Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORα J. Biol. Chem. 272:1997;22401-22404.
6. Raspé E., Duez H., Gervois P., Fievet C., Fruchart J.-C., Besnard S., Mariani J., Tedgui A., Staels B. Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORα J. Biol. Chem. 276:2001;2868-2871.
7. Delerive Ph., Chin W.W., Suen Ch.S. Identification of Reverα as a Novel RORα Target Gene. J. Biol. Chem. 277:2002;35013-35018.
8. Dussault I., Fawcett D., Matthyssen, A., Bader J.A., Giguere V. Orphan nuclear receptor RORα-deficient mice display the cerebellar defects of staggerer. Mech. Dev. 70:1998;147-153.
9. Steinmayr M., Andre E., Conquet F., Rondi-Reig L., Delhaye-Bouchaud N., Auclair N., Daniel H., Crepel F., Mariani J., Sotelo C., Becker-Andre M. Staggerer phenotype in retinoid-related orphan receptor α-deficient mice. Proc. Natl. Acad. Sci. USA. 95:1998;3960-3960.
10. Matsui T., Sashihara S., Oh Y., Waxman S.G. An orphan nuclear receptor, mROR alpha, and its spatial expression in adult mouse brain. Mol. Brain Res. 33:1995;217-226.
11. Kopmels B., Mariani J., Delhaye-Bouchaud N., Audibert F., Fradelizi D., Wollman E.E. Evidence for a hyperexcitability state of staggerer mutant mice macrophages. J. Neurochem. 58:1992;192-199.
12. Delerive P., Monté D., Dubois G., Trottein F., Fruchart-Najib J., Mariani J., Fruchart J.C., Staels B. The orphan nuclear receptor RORα is a negative regulator of the inflammatory response. EMBO Rep. 2:2001;42-48.
13. Mamontova A., Seguret-Mace S., Esposito B., Chaniale C., Bouly M., Delhaye-Bouchaud N., Luc G., Staels B., Duverger N., Mariani J., Tedgui A. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORα Circulation. 98:1998;2738-2743.
14. Meyer T., Kneissel M., Mariani J., Fournier B. In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc. Natl. Acad. Sci. USA. 97:2000;9197-9202.
15. Repa J.J., Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16:2000;459-481.
16. Morrison L.E. Time-resolved detection of energy transfer: theory and application to immunoassay. Anal. Biochem. 174:1988;101-120.
17. Glickman J.F., Wu X., Mercuri R., Illy C., Bowen B.R., He Y., Sills M.J. A comparison of ALPHAScreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors. J. Biomol. Screen. 7:2002;3-10.
18. Renaud J.P., Moras D. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57:2000;1748-1769.
19. Stehlin C., Wurtz J.M., Steinmetz A., Greiner E., Schüle R., Moras D., Renaud J.P. X-ray structure of the orphan nuclear receptor RORβ ligand-binding domain in the active conformation. EMBO J. 20:2001;5822-5831.
20. Kallen J., Schlaeppi J.M., Bitsch F., Geisse S., Geiser M., Delhon I., Fournier B. X-ray structure of the hRORα LBD at 1.63 .ANG.: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORα Structure. 10:2002;1-20.
21. Bourguet W., Vivat V., Wurtz J.M., Chambon P., Gronemeyer H., Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell. 5:2000;289-298.
22. Bourguet W., Andry V., Iltis C., Klaholz B., Potier N., Van Dorsselaer A., Chambon P., Gronemeyer H., Moras D. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis. Protein Expression Purific. 19:2000;284-288.
23. Billas I.M.L., Moulinier L., Rochel N., Moras D. Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J. Biol. Chem. 276:2001;7465-7474.
24. Dhe-Paganon S., Duda K., Iwamoto M., Chi Y.I., Shoelson S.E. Crystal structure of the HNF4α ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem. 277:2002;37973-37976.
25. Wisely G.B., Miller A.B., Davis R.G., Thornquest A.D., Johnson R., Spitzer T., Sefler A., Shearer B., Moore J.T., Miller A.B., Willson T.M., Williams S.P. Hepatocyte Nuclear Factor 4 is a transcription factor that constitutively binds fatty acids. Structure. 10:2002;1225-1234.
26. Pramanik B.N., Bartner P.L., Mirza U.A., Liu Y.H., Ganguly A.K. Electrospray ionization mass spectrometry for the study of non-covalent complexes: an emerging technology. J. Mass Spectrom. 33:1998;911-920.
27. Potier N., Donald L.J., Chernushevich I., Ayed A., Ens W., Arrowsmith C.H., Standing K.G., Duckworth H.W. Study of a noncovalent trp repressor:DNA operator complex by electrospray ionization time-of-flight mass spectrometry. Protein Sci. 7:1998;1388-1395.
28. Veenstra T.D. Electrospray ionization mass spectrometry in the study of biomolecular non-covalent interactions. Biophys. Chem. 79:1999;63-79.
29. Rocchi S., Picard F., Vamecq J., Gelman L., Potier N., Zeyer D., Dubuquoy L., Bac P., Champy M.F., Plumnket K.D., Leesnitzer L.M., Blanchard S.G., Desreumaux P., Moras D., Renaud J.P., Auwerx J. A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8:2001;737-747.
30. Potier N., Lamour V., Poterszman A., Thierry J.C., Moras D., Van Dorsselaer A. Characterization of crystal content by ESI-MS and MALDI-MS. Acta Cryst. D. 56:2000;1583-1590.
31. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., Van Dorsselaer A., Moras D., Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell. 9:2002;303-313.
32. Cohen A., Hertz H.S., Mandel J., Paule R.C., Schaffer R., Sniegoski L.T., Sun T., Welsch M.J., White V.E. Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. Clin. Chem. 26:1980;854-860.
33. Blum W., Aichholz R. Hochtemperatur Gas Chromatographie. 1991;Hüthig Verlag, Weinheim.
34. Lemaire D., Marie G., Serani L., Laprevote O. Stabilization of gas-phase noncovalent macromolecular complexes in electrospray mass spectrometry using aqueous triethylammonium bicarbonate buffer. Anal. Chem. 73:2001;1699-1706.
35. Rogniaux H., Van Dorsselaer A., Barth P., Bielmann J.F., Barbaton J., van Zandt M., Chevrier B., Howard E., Mitschler A., Potier N., Urzhumtseva L., Moras D., Podjarny A. Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies. J. Am. Soc. Mass Spectrom. 10:1999;635-647.
36. Atkins G.B., Hu X., Guenther M.G., Rachez Ch., Freedman L.P., Lazar M.A. Co-activators for the orphan nuclear receptor RORalpha. Mol. Endocrinol. 13:1999;1550-1557.
37. Cook R.P. Cholesterol. Chemistry, Biochemistry and Pathology. 1958;Academic Press, New York.
38. Gilbert L.I., Rybczynski R., Warren J.T. Control and biochemical nature of the ecdysteroidogenic pathway. Annu. Rev. Entomol. 47:2002;883-916.
39. Mathews C.K., van Holde K.E., Ahern K.G. Biochemistry. 2000;Benjamin/Cummings Publishing Company, Redwood City.
40. Schroepfer G.J. Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80:2000;361-554.
41. Nwokoro N.A., Wassif C.A., Porter F.D. Genetic disorders of cholesterol biosynthesis in mice and humans. Mol. Genet. Metabol. 74:2001;105-119.
42. Moraitis A.N., Giguère V., Thomson C.C. Novel mechanism of nuclear receptor co-repressor interaction dictated by activation function 2 helix determinants. Mol. Cell. Biol. 22:2002;6831-6841.